Journal article
Outcomes in Patients With Clinical Stage III NSGCT Who Achieve Complete Clinical Response to Chemotherapy at Extraretroperitoneal Disease Site
Abstract
OBJECTIVE: To compare the survival outcomes of patients with advanced nonseminoma and extraretroperitoneal (ERP) disease observed for a clinical complete response (CCR) with those demonstrating a pathologic complete response (PCR).
METHODS: From 1989 to 2003, 237 patients with clinical Stage III nonseminoma underwent induction chemotherapy followed by retroperitoneal lymph node dissection. After chemotherapy, 107 demonstrated a CCR to treatment …
Authors
Masterson TA; Carver BS; Shayegan B; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
Journal
Urology, Vol. 79, No. 5, pp. 1079–1084
Publisher
Elsevier
Publication Date
May 2012
DOI
10.1016/j.urology.2011.11.090
ISSN
0090-4295
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdolescentAdultAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorChorionic Gonadotropin, beta Subunit, HumanCisplatinDisease ProgressionDisease-Free SurvivalFollow-Up StudiesHead and Neck NeoplasmsHumansKaplan-Meier EstimateLiver NeoplasmsLung NeoplasmsLymph Node ExcisionLymphatic MetastasisMaleMediastinal NeoplasmsMiddle AgedNeoplasm, ResidualNeoplasms, Germ Cell and EmbryonalOrchiectomyProportional Hazards ModelsRadiographyRetroperitoneal SpaceTesticular NeoplasmsTreatment OutcomeYoung Adultalpha-Fetoproteins